PTC Therapeutics, Inc. - Common Stock (PTCT) stock analysis
PTCT · PTC Therapeutics, Inc. - Common Stock
Latest recorded price: USD 60.97
Sector and industry: Healthcare · Biotechnology
A reliable intrinsic value could not be calculated for PTCT; the assessment relies on sector multiple comparisons. Fiscal 2025 figures: revenue growth 35.3%, free cash flow margin 40.6%. The model flags 1 risk signal for this company.